Gwen A. Melincoff's most recent trade in Gain Therapeutics Inc was a trade of 15,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gain Therapeutics Inc | Gwen A. Melincoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Gain Therapeutics Inc | Gwen A. Melincoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Collegium Pharmaceutical Inc | Gwen A. Melincoff | Director | 16 May 2024 | 7,693 | 52,468 (0%) | 0% | 0 | Common Stock | ||
| Gain Therapeutics Inc | Gwen A. Melincoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Soleno Therapeutics Inc | Gwen A. Melincoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | Gwen A. Melincoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
| Collegium Pharmaceutical Inc | Gwen A. Melincoff | Director | 18 May 2023 | 9,792 | 44,775 (0%) | 0% | 0 | Common Stock | ||
| Gain Therapeutics Inc | Gwen A. Melincoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Soleno Therapeutics Inc | Gwen A. Melincoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
| Collegium Pharmaceutical Inc | Gwen A. Melincoff | Director | 19 May 2022 | 14,035 | 34,983 (0%) | 0% | 0 | Common Stock | ||
| Soleno Therapeutics Inc | Gwen A. Melincoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 31,862 | 31,862 | - | - | Employee stock option (right to buy) | |
| Collegium Pharmaceutical Inc | Gwen A. Melincoff | Director | 20 May 2021 | 9,941 | 20,948 (0%) | 0% | 0 | Common Stock | ||
| Soleno Therapeutics Inc | Gwen A. Melincoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 40,000 | 81,887 | - | - | Employee stock option (right to buy) |